New blood tests could speed up sepsis detection

NCT ID NCT04203979

Recruiting now Knowledge-focused Sponsor: Oslo University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is observing about 1,950 emergency patients with suspected sepsis to see if new blood tests (like calprotectin and bacterial DNA tests) can detect infections faster and more accurately than current methods. The goal is to find better ways to diagnose sepsis and tailor care to each patient. No new treatments are being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could lead to faster and more accurate sepsis diagnosis, enabling personalized treatment for patients.
What could go wrong: This is an observational study, not a treatment trial. It may not directly change patient care, and results may not apply to all hospitals or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis Systemic Inflammatory Response Syndrome toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPSIS SEPSIS SEVERE SEPSIS SYNDROME SEPTIC SHOCK

Contacts and locations

Locations

Oslo University Hospital
RECRUITING

Oslo, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.